spacer
home > pmps > spring 2017 > packaging for people
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Packaging for People

Developments in Europe since the first EU legislation in 1992 have led to a substantial standardisation of medicinal packaging. The law demands a combination of outer packaging, an inner container and a leaflet, and most drugs across Europe are now packed in a very similar way. This, of course, has major benefits for the pharmaceutical trade and for regulatory controls as it is relatively easy to compare prices and check legal compliance.

However, the perspective of the actual user is rarely considered. One reason might be that this point of view is more difficult to quantify and control. There are different ways in which drugs can be obtained (with or without a prescription) and numerous situations in which they are used (home, hospital, emergency). They are handled by several different people (healthcare professionals, carers, patients), all of whom differ in age, experience, language and reading abilities. Until now, this variety has been almost completely ignored in the packaging designs – there is only a ‘one-size-fits-all’ standard.

A second reason that the user perspective has not attracted much attention might be that production developments and continuous modifications to the regulations about packaging and leaflets has demanded most of the time and effort. There is rarely any time to consider what the consequences of legal compliance are on the people who handle medicines in care situations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Karel van der Waarde is a researcher and consultant for Graphic Design- Research, a company that writes, designs and tests packaging, package inserts and visual information about medicines. The focus is on a direct cooperation with people to develop digital formats and tangible instructions on labels, packaging and inserts. He holds a PhD from Reading University, UK, and has worked in the pharmaceutical industry ever since.
spacer
Dr Karel van der Waarde
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

Environmental Factors in Data Centres

Dycem

In addition to temperature and humidity, there are many more constraints in the environment that increase failure rates, explains Emilio Sapiña of Secure Techincal Rooms.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement